New Brain Imaging Technique Cuts MR Scan Time in Half

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 10
Volume 8
Issue 10

NEW ORLEANS-A new technique for magnetic resonance (MR) imaging can reduce brain scan time by half, according to a study from the Department of Radiology, University of Vienna, reported at the 99th annual meeting of the American Roentgen Ray Society. The new technique, T1-3D-echo-planar-imaging (EPI)-sequence, has diagnostic utility comparable to conventional T1-3D-gradient echo-sequence imaging, said lead investigator, Ahmed Ba-ssalamah, MD.

NEW ORLEANS—A new technique for magnetic resonance (MR) imaging can reduce brain scan time by half, according to a study from the Department of Radiology, University of Vienna, reported at the 99th annual meeting of the American Roentgen Ray Society. The new technique, T1-3D-echo-planar-imaging (EPI)-sequence, has diagnostic utility comparable to conventional T1-3D-gradient echo-sequence imaging, said lead investigator, Ahmed Ba-ssalamah, MD.

The two methods were compared in a group of 13 women and 28 men, with a mean age of 37 years. These 41 patients had a total of 78 lesions—71 tumors and 7 infections. Scans consisted of 140 overcontiguous partitions with an effective slice thickness of 2 mm and 1 mm of overlap. All slices were made in the coronal plane. Intravenous gadolinium was given as a contrast agent in all cases. The total scan time for gradient echo imaging was 4 minutes, 59 seconds; for the EPI technique it was 2 minutes, 20 seconds.

Images were assessed with both subjective and objective techniques. Subjective evaluation included lesion conspicuity (based on visibility of contrast delineation and extension of lesions) and image quality (based on grey-white matter differentiation, contrast medium enhancement, motion sensitivity, and chemical artifacts). The evaluation was made by two radiologists on a 4-point scale, with 4 being excellent. Objective image assessment was based on calculation of the signal-to-noise and contrast-to-noise ratios.

All lesions, regardless of size or location, were equally visible with either method. Gradient echo imaging was superior to the EPI technique with regard to lesion conspicuity and signal-to-noise ratio in both brain and tumor, and contrast-to-noise ratio in tumor, but the differences were not statistically significant.

Dr. Ba-ssalamah concluded that, because the 3D-EPI technique provides image quality similar to that of the conventional gradient echo technique with the advantage of reducing the scan time by 50%, it may replace conventional scanning. He indicated that the EPI method has been implemented at his institution, and neurosurgeons are very satisfied with the new technique.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Specialties including neurosurgery, radiation oncology, and neuro-rehabilitation all play a notable role in the care of patients with brain tumors.
Treatment-related toxicities during neuro-oncology therapy appear well managed with dose modifications and treatment cycle holds.
The phase 3 NIVOSTOP trial evaluated an anti–PD-1 immunotherapy, nivolumab, in a patient population similar in the KEYNOTE-689 trial.
CAR T-cell therapies appear to be an evolving modality in the treatment of those with intracranial tumors, said Sylvia Kurz, MD, PhD.
Opportunities to further reduce relapses include pembrolizumab-based combination therapy and evaluating the agent’s contribution before and after surgery.
For patients with locally advanced head and neck cancers, the current standard of care for curative therapy has a cure rate of less than 50%.
According to Maurie Markman, MD, patient-reported outcomes pertain to more relevant questions surrounding the impact of therapy for patients.
CancerNetwork® spoke with Neha Mehta-Shah, MD, MSCI, about the clinical landscape for patients undergoing treatment for rare lymphomas.
Related Content